Out-licensing
- Out-licensing
- View
Development of a Non-Invasive Transcervical Tubal Occlusion (Sterilization) in Women
Development of a Non-Invasive Transcervical Tubal Occlusion (Sterilization) in Women
Full description
Introduction/Background
In 1985, Platia and Krudy reported the first successful transcervical catheterization of one obstructed fallopian tube in a woman with bilateral tubal obstruction. Since then a number of reports have documented successful retrograde tubal cannulation.
Aims/Hypothesis
The reasons for pursuing new sterilization techniques for women are: (1) so that they can be performed in an outpatient setting with little or no morbidity, (2) eliminate the need for a general anaesthetic, (3) no post operative recovery, (4) no incisions, (5) be cost effective, (6) be simple and easy to perform, and (7) assure reliable contraception.
Results
A team of investigators at Dartmouth -Hitchcock Medical Center, Lebanon N.H. have developed an applicator designed to produce tubal occlusions in women for the purpose of sterilization (
In 1985, Platia and Krudy reported the first successful transcervical catheterization of one obstructed fallopian tube in a woman with bilateral tubal obstruction. Since then a number of reports have documented successful retrograde tubal cannulation.
Aims/Hypothesis
The reasons for pursuing new sterilization techniques for women are: (1) so that they can be performed in an outpatient setting with little or no morbidity, (2) eliminate the need for a general anaesthetic, (3) no post operative recovery, (4) no incisions, (5) be cost effective, (6) be simple and easy to perform, and (7) assure reliable contraception.
Results
A team of investigators at Dartmouth -Hitchcock Medical Center, Lebanon N.H. have developed an applicator designed to produce tubal occlusions in women for the purpose of sterilization (
Development status
Preclinical
Patent information
This technology is claimed in the United States Patent No. 6,485,486.
Related reports
Market Research Reports provided by reports.iptechex.com
Mar 2010 - 5 pages - $500
Mar 2011 - 38 pages - $500
Jun 2011 - 73 pages - $2,000
Jun 2011 - 184 pages - $2,500
Oct 2010 - 113 pages - $1,000
Oct 2011 - 60 pages - $500
Apr 2011 - 69 pages - $1,000
May 2011 - 25 pages - $125
May 2011 - 25 pages - $125
Licensing contact
Company details
Related technologies
- Elucidation of Antiangiogenic Agents for the Treatment of Endometriosis and Female Reproduction
- Elucidation of Novel Modulators of Fertility: Positive or Negative Regulators of Follicle Development
- Detection of Early Changes in Foetal EEG Due to Asphyxia with Acidemia During Labour
- Elucidation of a Target for Delaying Premature Labour
- Elucidation of Biomarkers for the Early Detection of Pre-eclampsia
Related categories
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us